{"nct_id":"NCT06379217","title":"NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-07-29","start_date_type":"ACTUAL","primary_completion_date":"2027-06-22","primary_completion_date_type":"ESTIMATED","completion_date":"2027-06-22","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["NVS"]}